Regardless of cancer type, patients with solid tumors could potentially benefit from a new vaccine for terminal cancer. In early February, experts reported 'extraordinary' results in previous trials involving terminally ill blood cancer patients.
Regardless of cancer type, patients with solid tumors could potentially benefit from a new vaccine for terminal cancer. In early February, experts reported 'extraordinary' results in previous trials involving terminally ill blood cancer patients.
Share this Article
Recommended